Current role of neoadjuvant and adjuvant systemic therapy for high-risk localized prostate cancer-Reference-Cited by-同舟云学术

Current role of neoadjuvant and adjuvant systemic therapy for high-risk localized prostate cancer

Published:2013-07 Issue:4 Volume:23 Page:366-371
ISSN:0963-0643
Container-title:Current Opinion in Urology
language:en
Short-container-title:

Author:

Dorff Tanya B.,Glode L. Michael

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference41 articles.

1. Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group protocol 85-31.;Pilepich;J Clin Oncol,1997

2. Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group protocol 92-02.;Hanks;J Clin Oncol,2003

3. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer.;Keating;J Clin Oncol,2006

4. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality.;Tsai;Ann Oncol,2007

5. Prevalent and incident use of androgen deprivation therapy among men with prostate cancer in the United States.;Gilbert;Urol Oncol Semin Orig Investig,2011

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Multiparametric MRI (mpMRI) in the Prediction of Adverse Prostate Cancer Pathology in Radical Prostatectomy Specimen;Urologia Internationalis;2024

2. Synthesis, bioactivity, and molecular docking of novel arylpiperazine derivatives as potential AR antagonists;Frontiers in Chemistry;2022-08-15

3. Synthesis and pharmacological evaluation of naftopidil-based arylpiperazine derivatives containing the bromophenol moiety;Pharmacological Reports;2020-01-23

4. Synthesis, biological evaluation and molecular docking of 4-Amino-2H-benzo[h]chromen-2-one (ABO) analogs containing the piperazine moiety;Bioorganic & Medicinal Chemistry;2019-10

5. Synthesis and biological evaluation of arylpiperazine derivatives as potential anti-prostate cancer agents;Bioorganic & Medicinal Chemistry;2019-01